share_log

Chardan Capital Maintains Buy on Coya Therapeutics, Raises Price Target to $14

Chardan Capital Maintains Buy on Coya Therapeutics, Raises Price Target to $14

Chardan Capital维持对Coya Therapeutics的买入,将目标股价上调至14美元
Moomoo 24/7 ·  03/20 05:31

Chardan Capital analyst Keay Nakae maintains Coya Therapeutics (NASDAQ:COYA) with a Buy and raises the price target from $11 to $14.

Chardan Capital分析师Keay Nakae维持Coya Therapeutics(纳斯达克股票代码:COYA)的买入并将目标股价从11美元上调至14美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发